Al Razi profit rises 5% to SAR 606,000 in H1 2023

31/08/2023 Argaam Exclusive

View other reports

Share Price

Al-Razi Medical Co.
50.00
0.00 0.00 %

Al-Razi Medical Co. (ALRAZI)

More

Al Razi Medical Co. reported a 5% increase in H1 2023 net profit to SAR 606,000, from SAR 580,000 in the year-earlier period, driven by better sales.



Financials (M)

Item 6m 2022 6m 2023 Change‬
Revenues 24.07 30.54 26.9 %
Gross Income 7.10 9.15 29.0 %
Operating Income 0.77 1.00 29.6 %
Net Income 0.58 0.61 4.6 %
Average Shares 1.52 1.52 -
EPS (Riyals) 0.38 0.40 4.6 %


Total shareholders’ equity, no minority interest, rose to SAR 23.04 million as of June 30, 2023, from SAR 22.93 million a year earlier.

 

Historical Data

Period

Revenue

(SAR mln)

Net Profit

(SAR mln)

EPS

(SAR)

H1 2022

24.07

0.58

0.38

H2 2022

28.32

1.43

0.94

H1 2023

30.54

0.61

0.40

 

View More Financial Results

 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.